Point of Care Diagnostics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

Point of Care Diagnostics Market Trends & Summary

The point-of-care diagnostics market is expected to increase from US$ 50.08 billion in 2024 to US$ 105.22 billion in 2033, indicating a compound annual growth rate of 8.60% from 2025 to 2033. This growth can be attributed to the progression in diagnostic technologies, demand for faster and more efficient testing, and awareness of benefits arising from accessible healthcare solutions in remote or underserved locations.

The report Point of Care Diagnostics Market & Forecast covers by Products (Glucose Monitoring Kits, Infectious Diseases Kits, Pregnancy & Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs Abuses Testing Kits), Technology (Lateral Flow, Agitation, flow through, solid phase, biosensor), Point of prescription (Prescription-Based Devices, Over-the-counter (OTC)-Based Devices), End-User (Professional Diagnostic Centers, Research Laboratories, Home Care, Others), Countries and Company Analysis 2025-2033.

Industry Overview: Point-of-Care Diagnostics

Point-of-care diagnostics, also known as point-of-care testing or near-patient testing, refers to medical testing carried out at or close to the location of patient care rather than in a central laboratory. POC tests yield rapid results, which often are reported in real time, so healthcare professionals can take treatment decisions in the same visit. POC diagnostics are applied in hospitals, clinics, outpatient care, and even in home settings.

POC testing encompasses a range of diagnostic applications, including blood glucose monitoring, pregnancy testing, infectious disease detection (such as COVID-19 or flu), and cholesterol levels. These tests can be conducted using portable devices that are easy to use and require minimal training. The main advantages of point-of-care diagnostics include quicker diagnosis, shorter waiting times, and better patient outcomes. Particularly with emergency care, remote, and underserved populations or chronic disease management, the advantage of POC diagnostics is to facilitate quicker interventions. The scope and precision of point-of-care diagnostics are also increasing with every technological advancement, making point-of-care diagnostics an imperative tool in modern healthcare systems.

Growth Drivers for Point of Care Diagnostics Market

Technological Advancement in Diagnostic Devices

The development of point-of-care diagnostics is promoted by advanced diagnostic technologies such as miniaturization, sensor integration, and artificial intelligence. Modern devices become more precise, portable, and user-friendly, thereby enabling health care providers to make quicker and more efficient testing decisions. Improved connectivity like Bluetooth and cloud-based systems ensure the real-time transfer of data, further increasing the speed of decision-making. This will allow point-of-care diagnostics to reach a wider cross-section of medical settings, opening avenues for expansion in the market.

Rising Prevalence of Chronic Diseases

Increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders is one major growth driver for the point-of-care diagnostics market. Continuous monitoring and early detection are essential for managing the said conditions effectively. The point-of-care devices allow patients and healthcare professionals to measure vital parameters such as blood glucose, cholesterol levels, and heart functions at home or on-site, reducing the need for frequent hospital visits. The convenience this offers is a key driver of demand for POC diagnostic solutions and supports growth in the market.

Increasing Demand for Rapid and Accessible Healthcare

The growing demand for rapid, easy, and cost-effective health care solutions is one of the factors that drive the growth of the point-of-care diagnostics market. Patients in remote or underserved areas are seeking immediate results, and POC diagnostics allow for quick testing and the making of timely treatment decisions. Moreover, the COVID-19 pandemic has demonstrated the need for accessible and rapid testing. As healthcare systems work to deliver effective care, there is growing demand for POC diagnostic tools that further enhance the industry's growth trend.

Obstacles in the Point of Care Diagnostics Market

Regulatory and Compliance Challenges

Regulatory issues pose some of the biggest problems to the point of care diagnostics market. Approvals for diagnostic devices have region-specific differences, with strict requirements for accuracy, safety, and performance. In many cases, manufacturers must navigate complex regulations from organizations like the FDA and CE Mark, which can delay product launches and increase costs. Compliance with these regulations is crucial to ensure patient safety and maintain trust in diagnostic results, making it challenging for market players to introduce innovative products quickly.

Accuracy and Reliability Concerns

Despite technological advancements, concerns over the accuracy and reliability of point-of-care diagnostic devices remain challenging. The main advantage of POC testing is convenience and speed. However, many devices might have lower sensitivity and specificity compared to lab tests, which can sometimes result in false positives or negatives that could influence clinical decision-making. Ensuring the accuracy of tests and consistency in quality across different settings is key to the broad adoption and trust in point-of-care diagnostics, an area where constant innovation in device technology and validation will be needed.

Infectious Diseases Kits Market

The Infectious Diseases Kits Market in the point-of-care diagnostics sector is growing rapidly, motivated by the demand for quicker, more accurate, and accessible disease detection. Point-of-care kits for infectious diseases provide immediate results for patients in hospitals, clinics, and even at home. These kits are critical to the management of COVID-19, influenza, and malaria outbreaks. Technological advancements in molecular diagnostics and antigen/antibody testing are enhancing the accuracy and speed of these tests, supporting market growth in global healthcare settings.

Agglutination Point-of-care Diagnostics Market

The Agglutination Point-of-Care (POC) Diagnostics Market is growing due to the demand for quick, reliable, and cost-effective diagnostic solutions. Agglutination-based tests use clumping of particles due to exposure to specific antibodies or antigens. This type of test is generally applied in the diagnosis of infectious diseases, blood typing, and some medical conditions. Agglutination tests give immediate results and, thus are used more commonly for emergencies and distant settings. Portable devices have emerged, along with health access in more recent times, driving growth within this market. However, challenges like sensitivity issues and regulatory hurdles may impact the adoption of agglutination POC diagnostics.

Prescription-Based Devices POC diagnostics market

The Prescription-Based Devices Point-of-Care (POC) Diagnostics Market is expanding due to the growing demand for personalized and accurate healthcare solutions. These devices require a prescription and are designed for monitoring and diagnosing specific conditions like diabetes, cardiovascular diseases, and respiratory infections. Prescription-based POC diagnostics provide the benefit of delivering comprehensive, precise results that assist in the proper management of chronic diseases. With advancements in medical devices and the growing accessibility of healthcare, the market is expanding. However, regulatory barriers and the requirement for appropriate healthcare provider involvement in prescribing these devices create obstacles.

Home Care POC diagnostics market

The Home Care Point-of-Care (POC) Diagnostics Market is experiencing a fast-growing trend since patients are more and more looking for the most convenient and cost-effective ways to monitor their health at home. Home care POC diagnostics include devices monitoring conditions like diabetes, hypertension, and cholesterol, letting people test and track their health without frequent visits to healthcare facilities. Advancements in user-friendly, accurate diagnostic devices and growing awareness about preventive healthcare are contributing to market expansion. Additionally, the COVID-19 pandemic accelerated demand for home-based testing. Challenges include ensuring accurate results, regulatory approval, and overcoming concerns about data privacy and device reliability.

Canada Point of Care Diagnostics Market

The Canada Point of Care (POC) Diagnostics Market is experiencing significant growth, driven by an increasing demand for rapid, accessible, and cost-effective healthcare solutions. This trend is mainly because of the increasing aging population and chronic diseases, including diabetes and cardiovascular conditions, which heightens the need for convenient diagnostic tools that provide real-time results. POC diagnostics, including glucose monitors, COVID-19 tests, and cholesterol screening, are becoming increasingly popular in various settings, such as hospitals, clinics, and homes. Other factors are mobile-connected devices and artificial intelligence, which are propelling the market forward. On the other hand, challenges with regulatory approval and reimbursement are significant concerns for the stakeholders in this market. BioLytical Laboratories Inc. recently received Health Canada authorization for this testing in point-of-care settings in March 2023.

France Point of Care Diagnostics Market

The France Point of Care (POC) Diagnostics Market is growing significantly due to an increased demand for quick, accurate, and easy-to-use diagnostic solutions within the healthcare industry. Factors responsible for this growth are a growing old population of France and the growing incidence of chronic diseases like diabetes, heart disease, and a host of infectious diseases. POC diagnostic devices, which encompass blood glucose monitors, cholesterol testing kits, and tools for infectious disease detection, are becoming more commonly utilized in a variety of settings, including hospitals, clinics, and home care environments. The French government's Health Innovation 2030 plan aims to make France a leader in European health innovation and sovereignty. The plan encompasses the creation of new bioclusters and university hospital institutes, the support extended towards medical research, and the formation of centers of excellence in health research.

China Point of Care Diagnostics Market

The China Point of Care diagnostics market is in tremendous growth as the demand for accessible, fast, and accurate healthcare solutions keeps increasing. The main drivers of growth in this market are that the country has a massive population, the incidence rate of chronic diseases such as diabetes and cardiovascular conditions continues to rise, and development of healthcare infrastructure. All these factors have led the POC devices, including glucose monitors, pregnancy tests, and diagnostics for infectious diseases, to be used by hospitals, clinics, and home settings. Further, technological advancements including the mobile health devices as well as the integration of telemedicine are further supplementing the growth of this market. Sept 2022, QuantuMDx Group has entered into collaboration deal with in-vitro diagnostic solution provider Sansure Biotech to fast-track the commercialization of Q-POC platform along with its assays across China.

UAE Point of Care Diagnostics Market

The UAE Point of Care (POC) Diagnostics Market is growing robustly and dynamically, mainly driven by the advanced healthcare infrastructure of the nation and an increasing demand for rapid, convenient, and precise diagnostic solutions. This growth is primarily driven by the increasing prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and respiratory illnesses, which are amplifying the need for efficient and timely testing methods. The UAE government is aggressively implementing programs that will ensure all the residents have access to better healthcare, including creating an awareness of the benefits associated with POC diagnostics. These initiatives, along with the massive technological advancements seen in mobile and digital diagnostics, are further propelling the growth of the POC diagnostics market. The continuing growth in the incidence of chronic diseases, support from the government as well as continued technological advancement will make POC diagnostics an essential part of the UAE's health profile. April 2022, PixCell Medical has signed an exclusive distribution agreement with United MakGroup Technologies L.L.C. to distribute HemoScreen in the UAE.

Products - Market breakup in 9 viewpoints:

1. Glucose Monitoring Kits

2. Infectious Diseases Kits

3. Pregnancy & Fertility Testing Kits

4. Haematology Testing Kits

5. Cardiometabolic Monitoring Kits

6. Urinalysis Testing Kits

7. Cholesterol Test Strips

8. Drugs Abuses Testing Kits

9. Others

Technology - Market breakup in 6 viewpoints:

1. Lateral Flow

2. Agitation

3. flow through

4. solid phase

5. biosensor

6. Others

Point of prescription - Market breakup in 2 viewpoints:

1. Prescription-Based Devices

2. Over-the-counter (OTC)-Based Devices

End-User - Market breakup in 4 viewpoints:

1. Professional Diagnostic Centers

2. Research Laboratories

3. Home Care

4. Others

Country - Market breakup of 25 Countries:

1. North America

• 1.1 United States
• 1.2 Canada

2. Europe

• 2.1 France
• 2.2 Germany
• 2.3 Italy
• 2.4 Spain
• 2.5 United Kingdom
• 2.6 Belgium
• 2.7 Netherlands
• 2.8 Turkey

3. Asia Pacific

• 3.1 China
• 3.2 Japan
• 3.3 India
• 3.4 South Korea
• 3.5 Thailand
• 3.6 Malaysia
• 3.7 Indonesia
• 3.8 Australia
• 3.9 New Zealand

4. Latin America

• 4.1 Brazil
• 4.2 Mexico
• 4.3 Argentina

5. Middle East & Africa

• 5.1 Saudi Arabia
• 5.2 UAE
• 5.3 South Africa

All the Key players have been covered from 3 Viewpoints:

• Overview
• Recent Development
• Revenue Analysis

Company Analysis:

1. Sysmex

2. Abbott Laboratories (US)

3. Becton Dickinson and Company (US)

4. Danaher Corporation (US)

5. Quidel Diagnostics (US)

6. F. Hoffmann-La Roche Ltd

7. Thermo Fisher Scientific Inc.

8. Bio-Rad Laboratories Inc.

Key Questions Answered in Report:

1. How big is the Point of Care Diagnostics industry?

The global Point of Care Diagnostics market size was valued at US$ 46.18 billion in 2023 and is expected to reach US$ 82.28 billion in 2030.

2. What is the Point of Care Diagnostics growth rate?

The global Point of Care Diagnostics market is expected to expand at a compound annual growth rate (CAGR) of 8.60 % from 2024 to 2030.

3. Who are the key players in Point of Care Diagnostics industry?

Some key players operating in the Point of Care Diagnostics market includes Sysmex, Abbott Laboratories (US), Becton Dickinson and Company (US), Danaher Corporation (US), Quidel Diagnostics (US), F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories Inc.

4. What are the factors driving the Point of Care Diagnostics industry?

Technological developments, the growing need for quick findings, the aging of the population, the prevalence of chronic diseases, the need for affordable healthcare options, and the trend toward decentralized healthcare settings are the main drivers of the Point of Care (POC) diagnostics market.

5. Which Region held the largest market share in the Point of Care Diagnostics industry?

North America is expected to hold the largest market share in the industry.

6. What segments are covered in the Point of Care Diagnostics Market report?

Products, Technology, Pont of Prescription, End User and Countries segment are covered in this report.